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Engineering an endocrine Neo-
Pancreas by repopulation of a 
decellularized rat pancreas with 
islets of Langerhans
H. Napierala1, K.-H. Hillebrandt1, N. Haep1, P. Tang1, M. Tintemann1, J. Gassner1, M. Noesser1, 
H. Everwien1, N. Seiffert1, M. Kluge1, E. Teegen1, D. Polenz1, S. Lippert1, D. Geisel2, A. Reutzel 
Selke1, N. Raschzok1, A. Andreou1, J. Pratschke1, I. M. Sauer1 & B. Struecker1,3
Decellularization of pancreata and repopulation of these non-immunogenic matrices with islets and 
endothelial cells could provide transplantable, endocrine Neo- Pancreata. In this study, rat pancreata 
were perfusion decellularized and repopulated with intact islets, comparing three perfusion routes 
(Artery, Portal Vein, Pancreatic Duct). Decellularization effectively removed all cellular components but 
conserved the pancreas specific extracellular matrix. Digital subtraction angiography of the matrices 
showed a conserved integrity of the decellularized vascular system but a contrast emersion into the 
parenchyma via the decellularized pancreatic duct. Islets infused via the pancreatic duct leaked from 
the ductular system into the peri-ductular decellularized space despite their magnitude. TUNEL staining 
and Glucose stimulated insulin secretion revealed that islets were viable and functional after the 
process. We present the first available protocol for perfusion decellularization of rat pancreata via three 
different perfusion routes. Furthermore, we provide first proof-of-concept for the repopulation of the 
decellularized rat pancreata with functional islets of Langerhans. The presented technique can serve as 
a bioengineering platform to generate implantable and functional endocrine Neo-Pancreata.
Type 1 diabetes mellitus (T1DM) is one of the most cost-intensive chronic diseases worldwide1,2. Insulin was 
discovered more than 90 years ago and has since been the main therapeutic agent in the management of T1DM; 
however, in some cases, exogenous insulin replacement is not able to provide the necessary metabolic regulation 
to prevent primary (hypoglycemic episodes)3 and secondary long-term complications (e.g., vasculopathy, cardio-
vascular diseases, diabetic nephropathy, neuropathy and retinopathy)4. In these severe cases, Β -cell replacement 
through pancreas or islet transplantation may be indicated.
Pancreas transplantation is a well-established procedure and (with regard to long term metabolic function) 
superior to islet transplantation5. However, in addition to rejection, major and occasionally life-threatening 
complications, such as post- transplant-pancreatitis, infections and thrombosis, continue to result in approxi-
mately 10% graft loss. Islet transplantation appears to be an alternative because it is less invasive and is there-
fore considered safer6. Although the indications to islet (auto-) transplantations are currently being expanded7, 
metabolic function after islet transplantation continues to suffer from various issues, such as the need for immu-
nosuppression and graft-site specific problems like hypoxia8, partial portal vein thrombosis9,10 and the instant 
blood-mediated inflammatory reaction (IBMIR)11.
With the development of novel tissue engineering techniques (e.g., decellularization and recellularization; 
Fig. 1), the above-mentioned issues could be overcome12. The intent of decellularization is to remove all cellular 
and antigenic material from an organ while preserving the innate and possibly non-immunogeneic, extracellu-
lar matrix (ECM). This matrix could be used for the bioengineering of transplantable organs via repopulation 
with (autologous) cells13–16. The ECM represents a biochemically, geometrically and spatially ideal platform17, 
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preserves basic matrix components, such as proteins and growth factors18, and retains an intact vasculature17. This 
environment could be the key to improved long-term islet survival and function after transplantation6.
Furthermore, by applying this technique it appears possible to engineer a solely endocrine Neo-Pancreas, 
which would prevent post-transplant pancreatitis because exocrine cells would not be used for the repopulation 
of the organ. The need for post-transplant immunosuppression could in the future be avoided, given that a proto-
col for the differentiation of fibroblasts into beta-like cells is already available19.
However, surprisingly, a limited number of studies have been published reporting on pancreas decellulariza-
tion and recellularization1,20–23 compared with other organs. To the best of our knowledge, no study is currently 
available reporting on whole rat pancreas decellularization, although a decellularized rat pancreas would render 
an interesting platform for tissue engineering experiments. Furthermore, no data is available on the repopulation 
of decellularized pancreas matrices with intact islets. Thus, it remains unclear, if the decellularized, parenchymal 
space can be repopulated with whole, intact islets, which are significantly bigger than other cells24.
Our aim was to find a rapid and reproducible protocol to decellularize whole rat pancreata and repopulate 
these matrices with intact Islets of Langerhans. Pancreas perfusion is possible through various perfusion routes 
(portal vein, aorta, extrahepatic bile duct and consecutively the pancreatic duct); thus, we evaluated these routes 
regarding decellularization effectiveness, ECM conservation, general handling and the possibility to infuse whole 
islets into the matrix. Furthermore, we evaluated if islets are still viable and functional after the process by ex vivo 
perfusion and glucose stimulated insulin secretion of repopulated Neo pancreata.
Results
Macroscopic observations during decellularization. During perfusion decellularization, a gradual loss 
of brownish color could be observed in all three groups until the organs appeared lucent (Fig. 2A–D).
After 1 hour (initial perfusion with Triton X-100) the organs remained opaque but elucidated compared with 
the beginning of the experiment (Fig. 2B). After 3 hours (end-point of the perfusion with SDS), the organs were 
completely translucent (Fig. 2C). This did not change until the end of the protocol (Fig. 2D). Macroscopically, the 
generated scaffolds were completely cell free but remained an intact network of vessel-like-structures.
Histological evaluation of decellularized matrices. Macroscopic observations were confirmed by H/E 
staining (Fig. 3): no cellular material was stained in the decellularized matrix, whereas the lobular structure of the 
pancreas could be preserved. Additionally, the connective tissue septa, as well as the ductal and vascular network 
were preserved in all specimens. Sirius red and Alcian Blue stainings were performed to visualize collagen fibers 
and acidic sulfated mucopolysaccharides as abundant components of the ECM, respectively (Fig. 3). The decellu-
larized ECM appeared identical to that of the controls in all cases. Microscopically, no relevant differences were 
observed between the three experimental groups (Fig. 3).
Immunohistochemical stainings were performed to visualize collagen IV, fibronectin and laminin as abun-
dant components of the ECM for a qualitative evaluation of the ECM after decellularization compared with the 
controls (Fig. 3). In all cases, the matrix proteins were detected inside the matrix and their distribution appeared 
comparable to native tissue. Again, no relevant differences were observed between the three experimental groups 
(Fig. 3).
Biochemical analysis of decellularized matrices. In all three experimental groups, the total DNA 
content declined significantly compared with the controls (Arterial Perfusion: 44.24 ± 11.58 μ g (p < 0.05); 
Portal Venous Perfusion: 67.49 ± 27.68 μ g (p < 0.5); Pancreatic duct perfusion: 59.73 ± 15.89 μ g (p < 0.5); C: 
687.0 ± 168.3 μ g (n = 6); Fig. 4A). No statistically significant differences between the three groups were found. 
The conservation of the main ECM components was confirmed via biochemical analysis showing remaining 
sGAG and hydroxyproline content in the matrix. A trend towards higher values could be observed for the sGAG 
Figure 1. Concept to generate an Endocrine Neo-Pancreas. A (xenogene) pancreas is decellularized by 
perfusion with alkaline detergents. The resulting non-immunogenic matrix conserves the organ specific 
extracellular matrix including the vascular and ductular protein network. The matrix is then repopulated by 
infusion of islets and endothelial cells to generate a functional and implantable organ.
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Figure 2. Macroscopic observations during decellularization. Time course of perfusion of three rat pancreata 
cannulated via the portal vein (PV), the pancreatic duct (PD) or the arterial system (A). At the initiation of the 
perfusion pancreata appear yellow to brown. Attached to the pancreata is the spleen in dark brown. One hour 
after perfusion with Triton X-100 pancreata start to lose their color and elucidate. After 2 hours of perfusion 
with SDS the pancreata appear completely transparent. The spleen is still brown because splenic blood vessels 
were ligated and not perfused. At the end of the decellularization process the organ structure is still conserved 
but the cellular components are removed.
www.nature.com/scientificreports/
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content/dry weight in the experimental groups compared with the native controls (A: 62.14 ± 10.52 μ g/mg 
(p < 0.5); PV: 56.26 ± 15.06 μ g/mg; BD: 60.32 ± 25.58 μ g/mg; C: 8.076 ± 4.081 μ g/mg; Fig. 4B). However, the 
only significant difference was found between the arterial perfusion group and the native controls. The collagen 
content/dry weight slightly increased in the three groups with different perfusion routes compared with the native 
controls (A: 164.3 ± 70.67 μ g/mg; PV: 108.9 ± 66.69 μ g/mg; BD: 287.4 ± 159 μ g/mg; C: 13.01 ± 2.573 μ g/mg; 
Fig. 4C). However, no significant differences could be found between the groups.
Contamination analysis of decellularized matrices. When a cell culture is contaminated with germs 
the culture medium becomes cloudy. Therefore, light absorbance levels of the culture medium was measured 
Figure 3. Histology of the decellularized pancreata. Pancreata that were decellularized via the Artery, the 
Portal Vein or the Pancreatic Duct were stained with different methods to analyze the organ structure after 
decellularization and compared with native controls: No remaining cells were found inside the decellularized 
organs but the characteristic lobular microarchitecture of the organ was preserved. Key matrix proteins 
(Collagen IV, Fibronectin and Laminin) were visualized by immunohistochemical stainings. No significant 
differences were observed between the three experimental groups. Key matrix proteins remained in the 
matrices.
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Figure 4. Biochemical evaluation. The amount of DNA significantly declined in all experimental groups 
compared to native controls (A). No statistically significant differences were observed between the experimental 
groups. The content of sulfated Glycosaminoglycans (sGAG) per dry weight (B) increased compared to native 
controls due to a loss of cellular protein mass. No statistically significant differences were observed between the 
experimental groups. The collagen content per dry weight (C) increased compared to native controls due to a 
loss of cellular protein mass. No statistically significant differences were observed between the experimental 
groups. Bioburden testing at 425 nm (D) and 600 nm (E) revealed that all experiments were sterile and not 
contaminated. Insulin analysis revealed that Insulin levels in the perfusate initially increased after high glucose 
perfusion and then were constant until the end of the perfusion (F).
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at 425 and 600 nm to analyze its turbidity and to quantify sterility of the decellularized matrices25. Bioburden 
analysis showed no change in the absorbance of any of the three experimental groups compared with the positive 
controls at both wavelengths throughout the experiment (Fig. 4D+E), indicating that the decellularized matrices 
remained sterile 96 hours after the process.
Digital subtraction analysis of decellularized matrices. The integrity of the vascular system within 
the decellularized pancreas was confirmed by angiography: Infusion of contrast agent via the arterial system and 
the portal vein showed an intact framework of the vessels with sparse emersion of contrast agent at the distal 
ends of the intra-pancreatic capillaries (Fig. 5). Angiography of the pancreatic duct showed a diffuse emersion of 
contrast agent along the ductular system into the parenchymal space (Fig. 5).
Scanning electron microscopy (SEM) of decellularized matrices. A comparison of native and decel-
lularized pancreata demonstrated the preservation of the three-dimensional microstructure after decellulariza-
tion (Fig. 6). SEM images of decellularized pancreata showed the conservation of matrix components. In contrast 
to the native controls, empty spaces surrounded by networks consisting of fibers with different calibers can be 
found inside the ECM. Intact protein networks of the blood vessels could be confirmed by the appearance of the 
Figure 5. Digital subtraction angiography (DSA) of decellularized pancreata. DSA revealed a major 
difference between pancreata, which were decellularized via the Artey or the Portal Vein and the Pancreatic 
Duct: Contrast agent that was infused via the vascular system followed the conserved vascular protein network 
and leaked into the decellularized parenchymal space at the ends of the intraparenchymatous vessels (black 
arrows). When infused via the pancreatic duct, the contrast agent followed the ductular system, too, but leaked 
into the decellularized parenchymal space along all along the ductular system. Some contrast agent leaked 
through extra-pancreatic vessels outside the organs (black arrowheads).
Figure 6. Scanning electron microscopy (SEM) of decellularized pancreata. SEM at a magnification of 1000 
and 2000 was performed to analyze the matrix composition after decellularization via the different perfusion 
routes and compare them with native controls. SEM showed intact protein fibers of the decellularized pancreata 
and empty cellular spaces compared to native controls. No significant differences were observed between the 
three experimental groups.
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internal elastic lamina without any residual endothelial cells. In the examined specimens, no relevant differences 
between the experimental groups were observed.
Evaluation of the repopulation process. During repopulation, islets were observed inside the vascular 
or ductular network of the decellularized pancreas, depending on the infusion route. Islets followed the flow of 
the perfusate inside the network from proximal to distal into the periphery of the organ. Some islets then leaked 
from the visible vascular or ductular network and entered the decellularized parenchymal matrix, while others 
remained inside the decellularized vessels. Interestingly, islets infused via the pancreatic duct seemed to enter the 
parenchymal matrix faster and easier. This observation was confirmed by H/E staining of the repopulated matri-
ces (Fig. 7): In total, more islets were found inside the organ, when infused via the pancreatic duct, compared to 
the aorta or the portal vein. Furthermore, more of these islets leaked into the parenchymal space. Since only a 
limited amount of islets and no other cells were infused, the majority of the decellularized space remained empty 
(Fig. 7).
Based on these observations two additional rat pancreata were repopulated via the pancreatic duct and used 
for ex vivo perfusion and glucose stimulated insulin secretion (GSIS) testing. In these experiments 17500 islets 
each were infused, using a multi-step recellularization protocol. Seeding efficiency of Experiment A and B was 
81.96% and 84.5%, respectively.
Viability and functionality of the Neo Pancreas grafts. At the beginning of the high glucose stimu-
lation, insulin levels were 178 ± 66 μ g/l and 163 ± 24 μ g/l, respectively. After 2 minutes of high glucose perfusion 
insulin in the perfusate increased to the highest values at 215 ± 54 μ g/l and 235 μ g/l, respectively. Then, insulin 
constantly decreased and was 39 μ g/l and 46 μ g/l after 30 minutes of perfusion (Fig. 4F). Even after 90 minutes of 
perfusion, insulin was still detectable in the perfusate (22 μ g/l and 40 μ g/l, respectively; data not shown) indicating 
an insulin production of the islets during the whole experiment.
Figure 7. H/E and TUNEL staining of the repopulated pancreata. At first the optimal route for the 
repopulation process was evaluated (A): When infused via the vascular system either islets were stuck inside 
the protein network of the vessels or were flushed through the organ. When infused via the pancreatic duct, 
islets leaked into peri-ductular parenchymal space. More islets were found in the pancreas repopulated via the 
pancreatic duct. Therefore further repopulation experiments were performed via the pancreatic duct (B): H/E 
staining confirmed the previous observations and showed many intact islets inside the decellularized space. 
TUNEL staining (red) revealed that islets are TUNEL negative and DAPI positive (blue) and therefore viable 
after the process.
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H/E and TUNEL staining confirmed that most of the islets remained intact after the manual infusion. Islets 
inside the decellularized pancreas matrix were negative for TUNEL staining, even after six hours of ex vivo perfu-
sion for the GSIS testing, showing that islets remained viable after the process (Fig. 7).
Discussion
The decellularization and recellularization of parenchymal organs has in recent years emerged in the field of tissue 
engineering. This interesting new technique could provide several improvements: by removing all cellular mate-
rial from an allogeneic or even xenogeneic organ, a less immunogenic three-dimensional scaffold can be gener-
ated that can be repopulated with xenogeneic, allogeneic or autologous cells. If the endothelial integrity inside the 
vascular network is re-established by e.g. re- endothelialization26 the engineered organ could finally be implanted 
in vivo. Recent proof-of-concept studies showed promising in-vivo results for various recellularized organs such 
as the heart, lung, liver and kidney27–30 but available data on pancreas decellularization remain limited1,20–23.
We provide the first protocol for rat pancreas decellularization and recellularization with whole islets. To 
analyze the impact of the perfusion route, three different experimental groups, that were identical with regard 
to applied perfusates, flow rates and duration, were evaluated. Interestingly, in contrast to our own results in the 
liver31 and to the results of Goh et al.21, who stated that decellularization via the pancreatic duct was insufficient, 
in the presented study, the perfusion route only appeared to have a minor impact on decellularization efficiency. 
In none of the examined specimens any remaining cells were found and the microstructures of the decellularized 
organs, including immunohistochemical stainings of the important matrix components, were comparable.
The only major difference between the three experimental groups was revealed by angiography: While con-
trast agent given via the vascular system remained mainly inside the framework of the vascular system and only 
leaked in to parenchyma at the distal ends of the capillaries, contrast agent infused via the pancreatic duct fol-
lowed the ductular system but spilled into the parenchymal space all along the ductular system. Thus, we hypoth-
esized that the pancreatic duct could be the best perfusion route for repopulation of decellularized pancreas 
matrices: Islets represent units of different cells and are significantly larger than single cells24. If the basal lamina 
of the vascular network is still intact after decellularization, infused islets should not be able to pass through the 
vascular protein network into the decellularized parenchymal space. We infused islets through the arterial system 
or the portal venous system or the pancreatic duct and confirmed our angiographic observations: When given 
via the vascular system, a high amount of the islets either remained inside the vascular system and got stuck or 
islets were just flushed through the organ. In contrast, islets given via the pancreatic duct left the ductular system 
and were found inside the parenchyma. Interestingly, a recent publication on human pancreas decellularization 
showed a survival of islets cultured on slices of the decellularized pancreas in a perifusion chamber. However, 
whole decellularized pancreata were not repopulated with islets, possibly due to their size22.
In our study, functionality of the repopulated grafts was evaluated by ex vivo perfusion and glucose stimu-
lated insulin secretion testing: Compared to physiological levels, we found relatively high glucose levels in the 
perfusate, which can be explained by a high number of islets used for the repopulation. Then, we found higher 
levels at the beginning of the perfusion with high glucose medium than we expected. This finding may result from 
different reasons: During the three hours of perfusion with low glucose medium we used a closed circuit to save 
perfusion medium. Then, after initiation of perfusion with high glucose the circuit was opened and fresh (high 
glucose) medium was inserted. Thus, secreted insulin might have accumulated in the circuit before initiation of 
high glucose perfusion. Furthermore, at least some islets will have been damaged during the process of repopu-
lation and therefore some insulin might have been released from perished islets. However, we are able to show a 
clear increase of insulin after initiation of perfusion with high glucose medium and found constant insulin levels 
during the further perfusion even with the open circuit. These findings clearly show that islets are functional after 
the repopulation process, as confirmed by TUNEL staining after the perfusion experiments.
If the vascular (and ductular) protein network of the organ is conserved, the cellular integrity of these struc-
tures can also be re-assembled with (for example) endothelial cells, as shown by Orlando et al.17. Complete 
re-endothelialization will be essential because thrombosis will otherwise become a major issue after implan-
tation32. In our study, the conservation of the vascular system was examined via macroscopic observation and 
confirmed in histological stainings, scanning electron microscopy and angiography. Thus, after parenchymal 
repopulation with islets, our next step will be the re-endothelialization of the vascular protein network.
However, we provide the first proof-of-concept that the parenchymal space of a decellularized pancreas can be 
repopulated with islets, despite their great size. We hypothesize that islets can leak into the parenchymal matrix 
through ruptures in the basal membrane of I) the conserved vascular protein network or even better II) through 
the protein network of the ductular system. In our experiments, repopulation via the pancreatic ductular system 
showed the most promising results. TUNEL staining and glucose stimulated insulin secretion revealed that islets 
remain viable and functional after the process.
Conclusion
To the best of our knowledge, we herein present the first available protocol for whole rat pancreas decellulari-
zation and recellularization with islets of Langerhans and compare three perfusion routes (arterial, venous and 
ductular). We provide proof-of-concept that the repopulation of decellularized rat pancreata is possible via the 
pancreatic duct and that islets remain viable and functional after the process. The presented technique can serve 
as a bioengineering platform for further recellularization and implantation studies.
Methods
Animals. All animal work was performed in accordance with local law and approved by the State Office of 
Health and Local Affairs (LAGeSo, Berlin, Germany; Reg. No. T0139/13, O0262/13 and O264/13).
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Forty-four male and female F344 DPP IV-, Wistar and Lewis eGFP rats (FEM, Charite ́ , Berlin, Germany) 
weighing between 150 and 400 g were used for the decellularization experiments.
Fifteen female outbred Wistar rats (Harlan Sprague Dawley Inc., Indianapolis, IN, USA) weighing between 
300 and 400 g were used for the islet isolation procedure.
Sterile conditions were maintained throughout all surgical procedures.
Rat Pancreas Harvesting. Rats were anaesthetized via the inhalation of isoflurane (abbvie, North Chicago, 
IL, USA) (3.5% for induction/2% for maintenance) and administered a subcutaneous injection of ketamine 
(Pfizer, New York City, NY, USA) (10 mg/kg), medetomidine hydrochloride (cp pharma, Burgdorf, Germany) 
(0.1 mg/kg) and metamizol (ratiopharm, Burgdorf, Germany) (100 mg/kg).
For perfusion via the portal vein (PV) and the abdominal aorta (A), the protocol for donor pancreatectomy 
published by Klempnauer and Settje33 was modified. We cannulated the designated vessel after injecting 500 IE of 
heparin (Rotexmedia, Trittau, Germany) into the inferior vena cava. The portal vein was cannulated retrogradely 
with a shortened 17 G catheter (Becton, Dickinson and Company, Franklin Lakes, NJ, USA). The aorta was can-
nulated retrogradely with a 17 G catheter after preparation of all branches. For the perfusion via the pancreatic 
duct (PD), the major duodenal papilla was exposed and ligated once with Silk 5–0. A small incision was made at 
common bile duct and a shortened 24 G catheter (Becton, Dickinson and Company) was inserted anterogradely.
All explanted organs were placed in a 100 ml beaker filled with cold Ringer-Lactate buffer and directly used for 
decellularization (PV, A and PD), or direct preparation for further analyses (Controls).
Perfusion Decellularization. To avoid contamination, the complete procedure was performed under sterile 
conditions in a laminar airflow cabinet (Heraeus Instruments, Hanau, Germany). The cannulated pancreata were 
connected to a perfusion system and 1% Triton X100 (Carl Roth, Karlsruhe, Germany) was perfused at 10 ml/min. 
for 60 minutes through the portal vein. Next, 0.5% sodium dodecyl sulfate (SDS) (Carl Roth) was used as a per-
fusate for 120 minutes. Again 1% Triton X-100 was used to perfuse the organs for 15 minutes at 10 ml/min. Then, 
phosphate-buffered saline solution pH 7.4 (PBS) (Biochrom, Berlin, Germany) was rinsed through the organs at 
2 ml/min. for 4 hours.
Islet isolation. Islet isolation was performed as described by Schubert et al.34. After euthanasia, a digestion 
solution containing Collagenase (Sigma-Aldrich, St. Louis, MO, USA) and DNase I (F. Hoffmann-La Roche, 
Basel, Switzerland) was injected anterogradely into the common bile duct. The pancreata were digested for 
15 min., islets were isolated with a discontinuous Ficoll (Sigma-Aldrich) gradient and cultured in RPMI 1640 
(Gibco, ThermoScientific, Venlo, Netherlands) supplemented with 10% (vol/vol) FBS (Biochrom). Purity and the 
amount of islets were determined using dithizone staining (Sigma-Aldrich).
Recellularization. At first recellularization was performed to test the best perfusion route: Isolated islets 
were reseeded on the decellularized matrix via a single-step perfusion technique. Approximately 2,000 islets in 
3 ml islet medium each were manually infused via the portal vein or the aorta or the pancreatic duct. The repop-
ulation process was performed under a M651 surgical microscope (Leica Microsystems, Wetzlar, Germany) and 
filmed with a MC170HD microscope camera (Leica Microsystems).
Further pancreata were recellularized with a modified technique via the pancreatic duct to test viability and 
functionality of the islets after the process: Decellularized pancreata were perfused with PBS 1 ml/min. overnight 
at room temperature. One hour before recellularization the organs were transferred into a petri dish filled with 
islet medium and incubated at 37 °C (95% O2/5% CO2). Recellularization was conducted using a 3-step manual 
infusion technique. At first, all cannulated outflows of the decellularized pancreas matrices were closed and 5 ml 
islet medium was infused via the extrahepatic bile duct. In total 6 ml islet medium with approximately 17,500 
islets was infused via the same route consisting of 2 min. infusion periods followed by 5 min. of static seeding.
Ex-vivo Perfusion and Glucose stimulated Insulin Secretion (GSIS). After repopulation, the recellu-
larized organs were connected to the perfusion reactor, kept at 37 °C (Fig. 8) but were not perfused for one hour to 
permit adherence of the islets inside the matrix. Then, the organs were perfused for 180 min. with low glucose islet 
medium (4 mmol/l) followed by a 90 min. perfusion with high glucose islet medium (20 mmol/l). Perfusion was 
performed via the cannulated arterial system. Perfusate freely flew out of the pancreas into the perfusion cham-
ber. Samples from the effluent inside the perfusion chamber were taken using a syringe at different time points 
and stored at − 20 °C before further analyses (Fig. 4F). Seeding efficiency was calculated by dithizone staining of 
the remaining islets inside the petri dish and inside the reactor at the end of the adherence time.
Histological evaluation. Paraformaldehyde-fixed (Herbeta Arzneimittel, Berlin, Germany) and 
paraffin-embedded (Sigma-Aldrich) tissue sections were cut 5-μ m-thick and stained with Hematoxylin and 
Eosin (AppliChem, Darmstadt, Germany), Alcian Blue (Morphisto, Frankfurt am Main, Germany) and Sirius 
Red (Sigma-Aldrich).
The immunohistochemistry staining for Collagen IV and Laminin used a 3% hydrogen peroxide solution, 
antigen retrieval with a 0.01 M citrate buffer (Agilent Technologies, Glostrup, Denmark) and 3% goat serum for 
blocking (Agilent Technologies). The sections were then incubated 1:400 with a rabbit anti-mouse polyclonal 
collagen IV antibody (Abcam, Cambridge, United Kingdom, Cat #ab6586) or 1:50 with a rabbit anti-mouse 
polyclonal laminin antibody (Abcam, Cat #ab11575) for 1 hour at 37 °C. The secondary goat anti-rabbit HRP 
antibody (Abcam, Cat #ab6721) was diluted 1:400 and incubated for 30 minutes followed by visualization with 
3,3′ -Diaminobenzidine (Agilent Technologies). Fibronectin staining included antigen retrieval with a 0.01 M 
citrate buffer, peroxidase block (Agilent Technologies) and protein block (Agilent Technologies). Sections were 
then incubated 1:100 with a rabbit polyclonal fibronectin antibody (Abcam, Cat #ab23751) at room temperature 
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overnight. LSAB System-HRP (Agilent Technologies) was used according manufacturer ́ s instructions and 3, 
3′ -Diaminobenzidine as substrate for visualization. Finally, all sections were counterstained with Mayer ́ s hema-
toxylin and mounted with Aquatex (Merck, Darmstadt, Germany).
To detect apoptosis inside the repopulated pancreas grafts we performed terminal deoxynucleotidyl trans-
ferase dUTP nick end labeling (TUNEL) staining using an In-Situ Cell Death Detection Kit, Fluorescein 
(F. Hoffmann-La Roche). To stain the tissue we used the labeling protocol for difficult tissue provided by the 
manufacturer. Afterwards the tissue was counterstained with DAPI (Sigma-Aldrich).
Images were recorded with a BZ-9000 BIOREVO microscope (Keyence, Osaka, Japan).
Biochemical analysis. For biochemical analysis, diethylpyrocarbonate (DEPC) (AppliChem) was 
added to the samples (n = 6 for each group), and they were homogenized with an Ultra-Turrax T25 (Janke 
& Kunkel IKA Labortechnik, Staufen, Germany). For DNA quantification, the DNeasy Blood & Tissue 
Kit (Qiagen, Venlo, Netherlands) was used to purify the DNA according to the protocol for small sam-
ple sizes provided by the manufacturer. The DNA content was measured using a NanoDrop 2000 C UV-Vis 
Spectrophotometer (ThermoScientific, Venlo, Netherlands) with a pre-configuration for DNA at 260 nm. For 
hydroxyproline detection, the Total Collagen Assay (QuickZyme, Leiden, Netherlands) was used following 
the instructions of the manufacturer. The hydroxyproline content was measured at an absorbance maximum 
of 570 nm with a FluoStar Optima (BMG Labtech, Ortenberg, Germany) and run against a standard curve 
(6–300 μ g/ml). The sGAG content was determined using a method described by Farndale et al.35. 1 ml of a 
1,9-Dimethylmethylene blue (Sigma-Aldrich) color reagent was mixed with the same amount of sample solu-
tion that had been incubated in a buffer containing papain and run directly at 525 nm on the NanoDrop 2000 C. 
A standard curve (0–200 μ g/ml) was obtained using Chondroitin-4-Sulphate (Carl Roth) with the same method.
A rat insulin ELISA (Mercodia AB, Uppsala, Sweden) was used to measure insulin levels in the perfusate. The 
protocol was performed according to the protocol provided by the manufacturer.
Bioburden analysis. To check for bacterial contamination, 5 ml of the perfusion perfusate was mixed with 
7 ml SOC medium in a partially opened 15 ml Falcon tube. The mixture was incubated at 37 °C and absorbance at 
425 and 600 nm was run against blank SOC medium with PBS after 24, 48, 72 and 96 hours using the NanoDrop 
2000 C.
Digital Subtraction Angiography. To visualize ductal and vascular anatomy, digital subtraction angiog-
raphy was performed in cooperation with the department of Radiology. A 1:1 mixture of Lipiodol (Guerbet, 
Villepinte, France) and Histoacryl (B. Braun, Melsungen, Germany) was used as a contrast agent. Images were 
acquired with an Allura Xper FD20/20 (Philips Medical Systems, Hamburg, Germany) angiography unit. After 
Figure 8. Scheme and photograph of the bioreactor for ex vivo perfusion. The reactor consisted of a 
perfusion chamber and two separate circuits for low and high glucose medium, each consisting of a pump, 
an oxygenator and a bubble trap. Two circuits were used to constantly circulate and oxygenate the perfusion 
medium and to ensure a fast switch from low to high glucose perfusion.
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flushing with 10% glucose solution, the contrast agent was injected manually into the cannulated portal vein, 
artery and pancreatic duct under fluoroscopic control.
Scanning electron microscopy (SEM). Scanning electron microscopy was performed by the electron 
microscopy core facility at the Charité Universitätsmedizin Berlin. The samples were fixated with 2.5% gluta-
raldehyde in 0.1 M sodium cacodylate buffer, rinsed, post-fixated with 1% osmium tetroxide and rinsed again. 
Then, the specimens were dehydrated with an ascending row of ethanol and critical-point-dried in a Polaron 
E3000 (Quorum Technologies, Laughton, United Kingdom). The samples were mounted on an aluminum pin 
and sputter-coated with a gold/palladium alloy to generate conductivity with a MED 020 (BAL-TEC, Balzers, 
Liechtenstein).
Pictures were taken with a DSM 982 Gemini (Zeiss, Oberkochen, Germany).
Statistical analysis. Statistical analysis and visualization were performed using Prism 6.0 g for Mac OS X 
(GraphPad Software Inc., La Jolla, CA, USA). Numeric data were expressed as the means ± standard error of 
means (SEM). Because a normal distribution could not be assumed due to the small sample size, group compari-
sons were performed using the Kruskal-Wallis test followed by Dunn ́ s multiple comparison analysis. Probability 
values p < 0.05 were regarded as statistically significant.
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